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IMMUNE RECONSTITUTION AND INFECTIOUS COMPLICATIONS IN CORD
BLOOD TRANSPLANT PATIENTS
Leen, A.M.1, Saliba, R.2,Maewal, I.3, Ku, S.1, Katari, U.1, Tripic, T.1, de
Lima, M.2, Alousi, A.2, Shpall, E.J.2, Bollard, C.M.1 1Baylor College of
Medicine, Texas Children’s Hospital, The Methodist Hospital, Houston,
TX; 2MD Anderson, Houston, TX; 3MD Anderson, Houston, TX
Umbilical cord blood grafts are increasingly used as a source of
hematopoietic stem cells for patients with high-risk hematologic
diseases. Despite appropriate CD341 cell numbers after transplan-
tation, immune recovery remains delayed and insufficient, and in-
fection-related morbidity remains a leading cause of mortality in
this patient group. The purpose of this study was to (i) evaluate
the tempo of functional T cell immune reconstitution after cord
blood transplant (CBT) using the IFNg ELIspot to measure the
frequency of T cells reactive against common viruses including
EBV, CMV, adenovirus (Adv), BK virus, influenza, and Respiratory
syncytial virus (RSV), as well as Staphylococcal enterotoxin B from
Staphylococcus aureus (Staph) at sequential timepoints pre- and
post transplant, and (ii) to delineate the types of infections in the
post-CBT period and how frequently they occur.
To assess immune reconstitution we prospectively isolated
PBMCs from 52 CBT recipients before and then at monthly inter-
vals after transplant. We assessed immune function by co-culturing
the cells with Staph as well as pepmixes (15mer peptide libraries)
spanning the viral antigens pp65 and IE1 (CMV), LMP1, LMP2,
EBNA1, EBNA3a, EBNA3b, EBNA3c, BZLF1 (EBV), hexon
and penton (Adv), VP1 and large T (BK virus), MP1 and NP1 (In-
fluenza), and N and F (RSV).We were consistently able to detect T
cell reactivity to Staph (median 395.5 spot forming cells (SFC)/
2x105, range 23-845.5) pre-transplant, but evidence of immune re-
covery was delayed until at least 6 months post-CBT with an aver-
age of 86 SFC/2x105, which increased to normal (pre-transplant
levels) by approx. 9 months post-transplant. Recovery of virus-spe-
cific T cells, exemplified by CMV-specific immune reconstitution,
was even more delayed with recovery to detectable levels (ave. 89
SFC/2 x105 cells) at the 9 month time point. In a small subset of pa-
tients viral reactivation appeared to accelerate recovery of T cells
reactive against the infecting virus with a subsequent decrease in vi-
ral load suggesting that the reconstituting cells had direct anti-viral
activity in vivo. We also retrospectively evaluated the incidence of
viral, bacterial, and fungal infections after CBT in the same patient
cohort. Approximately 30 of the patients that received a CBT died
within two years of transplant with 18 of these patients succumbing
to infection. The statistical analysis and conclusions are in progress
and will be presented.212
REGULATORY T CELLS FACILITATE THYMIC RECOVERY AFTER HSCT BY
DIRECTLY ENHANCING IMMIGRATION OF DONOR DERIVED THYMIC
PROGENITORS
Langfitt, D., Parish, C., Dallas, M.H. St. Jude Children’s Research
Hospital, Memphis, TN
Little is known regarding the mechanisms regulating thymic re-
covery after HSCT. Previously, we reported that dendritic cells
(DCs) accelerate thymic recovery as well as enhance T cell recon-
stitution after HSCT. DCs in the thymus are capable of inducing
regulatory T cells (Tregs) differentiation and Tregs are able to
enhance immune reconstitution by preventing GVHD-induced
damage of the thymic microenvironment. However the direct ef-
fect of Tregs on thymic recovery has not been described. Using
a syngeneic transplant model with a GFP1FOXP3 promoter, we
show that Tregs are able to enhance T cell recovery after
HSCT by directly enhancing the immigration of thymic progen-
itors. Lethally irradiated C57BL/6 (CD45.2) recipients received
103 (CD45.1) lin-sca-11c-kit1 (LSK) HSC progenitors or 103
(CD45.1) LSK cells along with ex vivo expanded
(CD45.11GFP1FOXP31) Tregs. On 4 and 7 days after HSCT,
thymuses of the Tregs groups contained 1.5 and 2-fold highernumber of thymocytes compared to control group, respectively.
Furthermore, thymuses of the Tregs group contained 10-fold
higher number of thymoctyes derived from donor LSK cells
(CD45.1) compared to control (p \ 0.05). Direct immigration
of thymic progenitors was confirmed by detection of donor
(CD45.11 GFP-) thymic progenitors using immunohistochemis-
try. Furthermore, peripheral blood of the Tregs group contained
3.1-fold higher numbers of CD31 cells derived from donor LSK
(CD45.1) cells compared to the control group. Lastly, we tested
whether the addition of Tregs is able to facilitate BM as well as
thymic engraftment. Lethally irradiated recipients received limit-
ing doses of LSK cells alone or LSK along with Tregs. One
month after HSCT, survival of the Tregs group was significantly
higher than control (50% versus 0%) (P 5 .04). Similar to the
thymus, we observed significant 7.2-fold increase in the number
of donor engraftment in the Tregs group compared to control.
The combined data suggest that Tregs plays a direct role in facil-
itating thymic and BM recovery to enhance immune reconstitu-
tion after HSCT.213
DONOR CD4 CELLS INDUCE HOST MICROENVIRONMENT INFLAMMA-
TION AFTER NONMYELOABLATIVE HEMATOPOIETIC CELL TRANSPLAN-
TATION WHICH SUPPRESSES HEMATOPOIESIS AND CONTRIBUTES TO
GRAFT REJECTION
Mueller, A.M.S.1, Florek, M.1, Hadeiba, H.2, Shizuru, J.A.1 1Stanford
University, Stanford, CA; 2Stanford University, Stanford, CA
The toxicity of allogeneic hematopoietic cell transplantation
(HCT) is reduced by nonmyeloablative (NM) conditioning; how-
ever, persistent host cells can exacerbate graft rejection. To study
the dynamics of hematopoietic reconstitution after NM radiation
in a minor-mismatched strain combination with high levels of en-
graftment resistance, BALB.K mice were given purified hemato-
poietic stem cells (HSC: cKit1Thy1.1loSca11Lin-) 1/- T cells
(TC) from AKR/J donors. Recipients of pure HSC or HSC1CD8
TC regularly achieved stable mixed chimerism. Mice given
HSC1CD41CD25- TC (CD4c) failed to engraft, displayed
BM hypocellularity compared with HSC recipients (median 3.8
vs 13.3  106 cells/2 legs; p 5 0.0003), and lymphopenia (\
5% vs . 40%) at 2 weeks (w) post-HCT. While the BM of
mice given HSC alone had all maturation stages of stem and pro-
genitor cells (HSC: cKit1Sca11Lin-Flt3-CD34-CD1501 [LT 5
long-term]/CD150- [ST 5 short term]; multipotent progenitors,
MPP: cKit1Sca11Lin-Flt31/-CD341/-), recipients of
HSC1CD4c lacked MPP, and their population of ST (. LT)
HSC was enlarged 2w post-HCT. These ST HSC were arrested
in G0/1, but promptly reconstituted multilineage hematopoiesis
when infused into unconditioned secondary Rag2gc2/2 recipi-
ents. At 2w post-HCT the BM, but not the spleen, of mice given
HSC1CD4c contained increased proportions of CD4 TC that
expressed high levels of CD69 (host . donor) and secreted
IFNg (donor: median 45%; host: 13% [p\ .001];\ 10% in all
other controls). Further, 1-2w post-HCT the BM dendritic cell
(DC) pool in mice given pure HSC was dominated by tolerogenic
plasmacytoid DC (CD11c1B2201), which were lacking in recip-
ients of HSC1CD4c. Rather, the BM of the latter contained pri-
marily myeloid DC (CD11c1Mac11), which strongly expressed
MHCII, CD40, CD80, and secreted IL-12. We evaluated several
other MHC-matched strain combinations, which demonstrated
lower levels of cytokine production and less impaired hematopoi-
esis. Overall, our data suggest that interactions between allo-acti-
vated donor CD4 TC and residual host cells create an
inflammatory environment involving the IL-12/IFNg axis which
results in inhibition of hematopoiesis with evidence of HSC qui-
escence. In contrast to the general view that TC augment donor
HSC engraftment, we observed improved donor chimerism in re-
cipients of pure HSC and postulate that this lack of CD4 TC
driven inflammation may result in superior immune reconstitu-
tion after NM conditioning.
